RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION
https://doi.org/10.20996/1819-6446-2011-7-1-26-30
Abstract
Aim. To evaluate the changes of respiratory function in patients with rheumatic heart disease (RHD) complicated with pulmonary hypertension (PH) by the spirographic investigation. Materials and methods. Patients (n=56; 4 men and 52 women; aged 63,25±7,93) with rheumatic combined mitral and aortic valvular disease were examined. Medical history analysis, physical examination, general clinical investigation including ECG, chest X-ray, 2D-echocardiography and spirography were performed. Results. 36% of the patients had normal pulmonary arterial systolic pressure (PASP) (<30 mm Hg), 48% had PH of degree I and 16% - PH of degree II. Restrictive changes of spirogram were found in 27% of patients: in 30% of patients with PH of degree I, in 44% of patients with PH of degree II and in 5% of patients with no PH. Bronchoobstruction was detected in no one patient. Pulmonary restriction significantly (p<0,05) correlated with PH, but no significant difference was found between groups with PH of I and II degree. No any association between PASP, spirogram changes and type of valvular lesion was revealed. Conclusion. Patients with RHD complicated with PH have pulmonary restrictive changes according to spirographic investigation.
About the Authors
N. A. Shostak
Russian State Medical University
Russian Federation
Russian Federation
A. A. Klimenko
Russian State Medical University
Russian Federation
Russian Federation
I. A. Novikov
Russian State Medical University
Russian Federation
Russian Federation
References
1. Folomeeva O.M., Galushko E.A., Erdes Sh.F. Prevalence of rheumatic diseases in the populations of the adult population in Russia and the United States. Nauchno-prakticheskaya revmatologiya 2008;4:4-13. Russian (Фоломеева О.М., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США. Научно-практическая ревматология 2008;4:4-13).
2. Belov B.S., Grishaeva T.P. Acute rheumatic fever: current approaches to primary and secondary prevention. Lechashchiy vrach 2007;6:99-101. Russian (Белов Б.С., Гришаева Т.П. Острая ревматическая лихорадка: современные подходы к первичной и вторичной профилактике. Лечащий врач 2007;6:99-101).
3. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology and the European Respiratory Society, endorsed by the International Society of Heart and Lung Transplantation. Eur Heart J 2009;30(20):2493-2537.
4. Gorbachevskiy S.V., Gorchakova A.I., Lepikhova I.I. Place an open lung biopsy in surgery of congenital heart disease with pulmonaryhypertension. Patologiya krovoobrashcheniya i kardiokhirurgiya 1998;1:9-11. Russian (Горбачевский С.В., Горчакова А.И., Лепихова И.И. Место открытой биопсии легкого в хирургии врожденных пороков сердца с легочной гипертензией. Патология кровообращения и кардиохирургия 1998;1:9-11).
5. Tamm M., Higenbottam T.W., Dennis C.M. et al. Donor and recipient predicted lung volume and lung size after heart-lung transplantation. Am J Respir Crit Care Med 1994;150(2):403-407.
6. Ioffe LTs, Dzhoshibaev SD, Men'shukova AA. Instantaneous velocity parameters of expiration in patients with congenital heart disease. Ter Arkh. 1989;61(4):91-3. Russian (Иоффе Л.Ц., Джошибаев С.Д, Меньшукова А.А. Мгновенные скоростные показатели выдоха у больного с врожденными пороками сердца. Терапевтический архив 1989;4:91-93).
7. Haworth S. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. Br Heart J 1984;52(5):557-71.
8. Hryniewiecki T., Rawczyńska-Englert I., Malinowski R., Gutkowski P. Analysis of airway function in patients with mitral valve disease in various stages of progression [in Polish]. Przegl Lek 1999;56(4):270-275.
9. Rybakova M.K., Alekhin M.N., Mit'kov V.V. A practical guide to ultrasound diagnosis: Echocardiography. Moscow: Vidar-M; 2008. Russian (Рыбакова М.К., Алехин М.Н., Митьков В.В. Практическое руководство по ультразвуковой диагностике: Эхокардиография. М.: Ви-дар-М; 2008).
10. Rebrova O.Yu. Statistical analysis of medical data. Application software package STATISTICA. Moscow: Mediasfera, 2002. Russian (Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: Медиасфера; 2002).
11. Plechev V.V., Evsyukov A.A., Kolyaskin A.A. Relationship morphofunctional indices of the lungs in patients with heart valve disease complicated by pulmonary hypertension. Proceedings of the International remote scientific conference dedicated to the memory of Professor V. Parin "The introduction of innovative technologies in surgical practice (basic and applied aspects). Perm,2008. Available on http://www.osurg.com/pages/ confpages/70.html. Russian (Плечев В.В., Евсюков А.А., Коляскин А.А. и др. Взаимосвязь морфофункциональных показателей легких у больных с пороками сердца, осложненными легочной гипертензией. Материалы Международной дистанционной научно-практической конференции посвященной памяти профессора В.Н. Парина «Внедрение инновационных технологий в хирургическую практику (фундаментальные и прикладные аспекты)». Пермь; 2008. Доступно на http://www.osurg.com/pages/confpages/70.html).
12. Kee K., Naughton M.T. Heart failure and the lung. Circ J 2010;74(12):2507-2516.
13. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119(16):2250-2294.
14. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114(5):e84-231.
Review
For citations:
Shostak N.A., Klimenko A.A., Novikov I.A. RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION. Rational Pharmacotherapy in Cardiology. 2011;7(1):26-30. (In Russ.) https://doi.org/10.20996/1819-6446-2011-7-1-26-30
Views: 1107
1.jpg)
.jpg)
Email this article 